Abstract SubmissionAgendaHome
Prior ConferencesFacultyVideos

MASH-TAG 2025 Presentation Slides

[The Year 2024 In Review]

- Michael Charlton, MD, MBBS, FRCP

SESSION 1: In-depth Expert Analysis of MASH Clinical Trials – 2024

[Tirzepatide Phase 2b]

- Quentin Anstee, BSc (Hons), MB BS, PhD, MRCP(UK), FRCP

[Survodutide Phase 2b]

- Rohit Loomba, MD, MHSc

SESSION 3: Refining Clinical Benefit in Outcome Trials

SESSION 4: The Promise of New Pharmacological Agents + Pathophysiology

[HSD17B13]

- Nikhil Vergis, MRCP, PhD

[PNPLA3]

- Stefano Romeo, MD, PhD

[FASN inhibitors]

- Marie O’Farrell, PhD

SESSION 8: Surveying the Post Approval Landscape

[Future of Combination Therapies]

- Phil Newsome, PhD, FRCPE

[How Did Clinical Practice Change with Resmetirom on the Market?]

- Manal Abdelmalek, MD, MPH, FACP, FACG, FAASLD

Links

Event Info

2025 ProspectusElm Planning

Event Email

Contact Us

All Copyright © Reserved by MASH-TAG